Qube Research & Technologies Ltd
Position in IRWD — Ironwood Pharmaceuticals Inc
CIK 1729829
LONDON, X0
Position in IRWD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,581,184
-$84,557 QoQ
Shares Held
1,590,081
-5.4% QoQ
Ownership
0.966%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $391,792,991 across 21 Drug Manufacturers - Specialty & Generic names. IRWD ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,666,750 | $130,597,792 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,441 | $73,198,044 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
686,853 | $33,071,971 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
498,198 | $25,751,854 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
4,114,425 | $23,863,665 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
621,935 | $20,567,390 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
210,130 | $16,158,997 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
429,363 | $13,086,984 |
All Filings in IRWD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,581,184 | 1,590,081 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,665,741 | 1,681,229 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,677,052 | 2,806,910 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,412,721 | 3,351,002 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,861,376 | 3,307,059 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,141,743 | 257,730 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,351,593 | 570,775 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $905,681 | 79,168 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $2,748,397 | 258,308 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,170,360 | 206,308 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,109,942 | 170,294 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,383,381 | 133,531 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,695,198 | 147,025 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $706,241 | 56,140 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,828,229 | 156,795 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $894,623 | 68,501 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $791,969 | 69,532 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $562,491 | 54,505 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $163,397 | 16,194 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||